Is Biofrontera Inc. (BFRIW) a Buy, Sell, or Hold?
NASDAQ : BFRIW
Biofrontera Inc. — News
$0.0231 USD
-$0.01 (-18.95%)
- Volume
- 1.78K
- Average Volume
- 5.7K
- Market Capitalization
- $8.9M
- P/E Ratio
- -0.97
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.10
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.20
| Source | Headline |
|---|---|
|
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
WOBURN, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026. globenewswire.com - 2026-05-21 09:15:00 |
